CDC-Authored Genomics and Precision Health Publications Database

---

Last data update: Nov 04, 2024. (Total: 6390 publications)

All Cancer Diabetes Economic Equity Environmental FHH HLBS ID Implementation ND PGx PI Rare RCH dataset

Filtered By: Select to fine-tune your search Year Journal

Next

Records 1-30 (of 48 Records)

Query Trace: Gubareva L[original query]
Antiviral susceptibility of swine-origin influenza a viruses isolated from humans, United States Gao R , Pascua PNQ , Chesnokov A , Nguyen HT , Uyeki TM , Mishin VP , Zanders N , Cui D , Jang Y , Jones J , La Cruz J , Di H , Davis CT , Gubareva LV . Emerg Infect Dis 2024 30 (11)
Multicountry spread of influenza A(H1N1)pdm09 viruses with reduced oseltamivir inhibition, May 2023-February 2024 Patel MC , Nguyen HT , Pascua PNQ , Gao R , Steel J , Kondor RJ , Gubareva LV . Emerg Infect Dis 2024 30 (7) 1410-1415
Antiviral susceptibility of clade 2.3.4.4b highly pathogenic avian influenza A(H5N1) viruses isolated from birds and mammals in the United States, 2022 Nguyen HT , Chesnokov A , De La Cruz J , Pascua PNQ , Mishin VP , Jang Y , Jones J , Di H , Ivashchenko AA , Killian ML , Torchetti MK , Lantz K , Wentworth DE , Davis CT , Ivachtchenko AV , Gubareva LV . Antiviral Res 2023 217 105679
Influenza Activity and Composition of the 2022-23 Influenza Vaccine - United States, 2021-22 Season. Merced-Morales A , Daly P , Abd Elal AI , Ajayi N , Annan E , Budd A , Barnes J , Colon A , Cummings CN , Iuliano AD , DaSilva J , Dempster N , Garg S , Gubareva L , Hawkins D , Howa A , Huang S , Kirby M , Kniss K , Kondor R , Liddell J , Moon S , Nguyen HT , O'Halloran A , Smith C , Stark T , Tastad K , Ujamaa D , Wentworth DE , Fry AM , Dugan VG , Brammer L . MMWR Morb Mortal Wkly Rep 2022 71 (29) 913-919
Susceptibility of widely diverse influenza a viruses to PB2 polymerase inhibitor pimodivir. Patel MC , Chesnokov A , Jones J , Mishin VP , De La Cruz JA , Nguyen HT , Zanders N , Wentworth DE , Davis TC , Gubareva LV . Antiviral Res 2021 188 105035
Detection of baloxavir resistant influenza A viruses using next generation sequencing and pyrosequencing methods. Patel MC , Mishin VP , De La Cruz JA , Chesnokov A , Nguyen HT , Wilson MM , Barnes J , Kondor RJG , Wentworth DE , Gubareva LV . Antiviral Res 2020 182 104906
Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2017-2018. Takashita E , Daniels RS , Fujisaki S , Gregory , Gubareva LV , Huang W , Hurt AC , Lackenby A , Nguyen HT , Pereyaslov D , Roe M , Samaan M , Subbarao K , Tse H , Wang D , Yen H-L , Zhang W , Meijer A . Antiviral Res 2020 175 104718-104718
Detection of oseltamivir-resistant zoonotic and animal influenza A viruses using the rapid influenza antiviral resistance test. Hodges EN , Mishin VP , De la Cruz J , Guo Z , Nguyen HT , Fallows E , Stevens J , Wentworth DE , Davis CT , Gubareva LV . Influenza Other Respir Viruses 2019 13 (5) 522-7
Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011-2018. Jorquera PA , Mishin VP , Chesnokov A , Nguyen HT , Mann B , Garten R , Barnes J , Hodges E , De La Cruz J , Xu X , Katz J , Wentworth DE , Gubareva LV . Sci Rep 2019 9 (1) 2676
Mapping of the US Domestic Influenza Virologic Surveillance Landscape. Jester B , Schwerzmann J , Mustaquim D , Aden T , Brammer L , Humes R , Shult P , Shahangian S , Gubareva L , Xu X , Miller J , Jernigan D . Emerg Infect Dis 2018 24 (7) 1300-6
Update: Influenza Activity in the United States During the 2017-18 Season and Composition of the 2018-19 Influenza Vaccine. Garten R , Blanton L , Elal AIA , Alabi N , Barnes J , Biggerstaff M , Brammer L , Budd AP , Burns E , Cummings CN , Davis T , Garg S , Gubareva L , Jang Y , Kniss K , Kramer N , Lindstrom S , Mustaquim D , O'Halloran A , Sessions W , Taylor C , Xu X , Dugan VG , Fry AM , Wentworth DE , Katz J , Jernigan D . MMWR Morb Mortal Wkly Rep 2018 67 (22) 634-642
Susceptibility of Brazilian influenza A(H1N1)pdm09 viruses to neuraminidase inhibitors in the 2014-2016 seasons: Identification of strains bearing mutations associated with reduced inhibition profile. Matos AR , Resende PC , Miranda MD , Garcia CC , Caetano BC , Lopes JCO , Debur MC , Cury ALF , Vianna LA , Lima MC , Schirmer M , Gubareva L , Hurt AC , Brown DW , Siqueira MM . Antiviral Res 2018 154 35-43
Drug Susceptibility Evaluation of an Influenza A(H7N9) Virus by Analyzing Recombinant Neuraminidase Proteins. Gubareva LV , Sleeman K , Guo Z , Yang H , Hodges E , Davis CT , Baranovich T , Stevens J . J Infect Dis 2017 216 S566-s574
Highly Pathogenic Avian Influenza A(H5N1) Viruses at the Animal-Human Interface in Vietnam, 2003-2010. Creanga A , Hang NLK , Cuong VD , Nguyen HT , Phuong HVM , Thanh LT , Thach NC , Hien PT , Tung N , Jang Y , Balish A , Dang NH , Duong MT , Huong NT , Hoa DN , Tho ND , Klimov A , Kapella BK , Gubareva L , Kile JC , Hien NT , Mai LQ , Davis CT . J Infect Dis 2017 216 S529-s538
A Pyrosequencing-Based Approach to High-Throughput Identification of Influenza A(H3N2) Virus Clades Harboring Antigenic Drift Variants. Mishin VP , Baranovich T , Garten R , Chesnokov A , Abd Elal AI , Adamczyk M , LaPlante J , George KS , Fry AM , Barnes J , Chester SC , Xu X , Katz JM , Wentworth DE , Gubareva LV . J Clin Microbiol 2016 55 (1) 145-154
Enhanced genetic characterization of influenza A(H3N2) viruses and vaccine effectiveness by genetic group, 2014-2015. Flannery B , Zimmerman RK , Gubareva LV , Garten RJ , Chung JR , Nowalk MP , Jackson ML , Jackson LA , Monto AS , Ohmit SE , Belongia EA , McLean HQ , Gaglani M , Piedra PA , Mishin VP , Chesnokov AP , Spencer S , Thaker SN , Barnes JR , Foust A , Sessions W , Xu X , Katz J , Fry AM . J Infect Dis 2016 214 (7) 1010-9
The molecular characterizations of surface proteins hemagglutinin and neuraminidase from recent H5Nx avian influenza viruses. Yang H , Carney PJ , Mishin VP , Guo Z , Chang JC , Wentworth DE , Gubareva LV , Stevens J . J Virol 2016 90 (12) 5770-5784
Detection and Characterization of Clade 1 Reassortant H5N1 Viruses Isolated from Human Cases in Vietnam during 2013. Thor SW , Nguyen H , Balish A , Hoang AN , Gustin KM , Nhung PT , Jones J , Thu NN , Davis W , Ngoc TN , Jang Y , Sleeman K , Villanueva J , Kile J , Gubareva LV , Lindstrom S , Tumpey TM , Davis CT , Long NT . PLoS One 2015 10 (8) e0133867
Application of a Seven-Target Pyrosequencing Assay To Improve the Detection of Neuraminidase Inhibitor-Resistant Influenza A(H3N2) Viruses. Tamura D , Okomo-Adhiambo M , Mishin VP , Guo Z , Xu X , Villanueva J , Fry AM , Stevens J , Gubareva LV . Antimicrob Agents Chemother 2015 59 (4) 2374-9
Oseltamivir-resistant influenza A(H1N1)pdm09 viruses, United States, 2013-14. Okomo-Adhiambo M , Fry AM , Su S , Nguyen HT , Elal AA , Negron E , Hand J , Garten RJ , Barnes J , Xiyan X , Villanueva JM , Gubareva LV . Emerg Infect Dis 2015 21 (1) 136-41
Use of highly pathogenic avian influenza A(H5N1) gain-of-function studies for molecular-based surveillance and pandemic preparedness. Davis CT , Chen LM , Pappas C , Stevens J , Tumpey TM , Gubareva LV , Katz JM , Villanueva JM , Donis RO , Cox NJ . mBio 2014 5 (6)
Antiviral susceptibility of highly pathogenic avian influenza A(H5N1) viruses isolated from poultry, Vietnam, 2009-2011 Nguyen HT , Nguyen T , Mishin VP , Sleeman K , Balish A , Jones J , Creanga A , Marjuki H , Uyeki TM , Nguyen DH , Nguyen DT , Do HT , Klimov AI , Davis CT , Gubareva LV . Emerg Infect Dis 2013 19 (12) 1963-71
Drug susceptibility surveillance of influenza viruses circulating in the United States in 2011-2012: application of the WHO antiviral working group criteria Okomo-Adhiambo M , Nguyen HT , Abd Elal A , Sleeman K , Fry AM , Gubareva LV . Influenza Other Respir Viruses 2013 8 (2) 258-65
The effect of the MDCK cell selected neuraminidase D151G mutation on the drug susceptibility assessment of influenza A(H3N2) viruses. Mishin VP , Sleeman K , Levine M , Carney PJ , Stevens J , Gubareva LV . Antiviral Res 2013 101 93-6
Cell culture-selected substitutions in influenza A(H3N2) neuraminidase affect drug susceptibility assessment Tamura D , Nguyen HT , Sleeman K , Levine M , Mishin VP , Yang H , Guo Z , Okomo-Adhiambo M , Xu X , Stevens J , Gubareva LV . Antimicrob Agents Chemother 2013 57 (12) 6141-6
Bioluminescence-based neuraminidase inhibition assay for monitoring influenza drug susceptibility in clinical specimens Marjuki H , Mishin VP , Sleeman K , Okomo-Adhiambo M , Sheu TG , Guo L , Xu X , Gubareva LV . Antimicrob Agents Chemother 2013 57 (11) 5209-15
Assays for monitoring susceptibility of influenza viruses to neuraminidase inhibitors Okomo-Adhiambo M , Sheu TG , Gubareva LV . Influenza Other Respir Viruses 2013 7 Suppl 1 44-9
Molecular epidemiology of influenza A(H1N1)pdm09 viruses from Pakistan in 2009-2010. Bashir Aamir U , Badar N , Mehmood MR , Nisar N , Suleman RM , Shaukat S , Sharif S , Kamran J , Zaidi SS , Kazi BM , Gubareva L , Xu X , Garten R , Klimov A . PLoS One 2012 7 (8) e41866
Monitoring seasonal influenza A evolution: rapid 2009 pandemic H1N1 surveillance with an reverse transcription-polymerase chain reaction/electro-spray ionization mass spectrometry assay Jeng K , Massire C , Zembower TR , Deyde VM , Gubareva LV , Hsieh YH , Rothman RE , Sampath R , Penugonda S , Metzgar D , Blyn LB , Hardick J , Gaydos CA . J Clin Virol 2012 54 (4) 332-6
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses De Marco D , Clementi N , Mancini N , Solforosi L , Moreno GJ , Sun X , Tumpey TM , Gubareva LV , Mishin V , Clementi M , Burioni R . PLoS One 2012 7 (3) e34415